• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

李·西尔弗曼嗓音治疗法(LSVT LOUD)对进行性核上性麻痹患者吞咽功能的影响:一项初步研究。

Effects of Lee Silverman Voice Treatment (LSVT LOUD) on Swallowing in Patients with Progressive Supranuclear Palsy: A Pilot Study.

作者信息

Nozaki Sonoko, Fujiu-Kurachi Masako, Tanimura Takako, Ishizuka Kimiyo, Miyata Eri, Sugishita Shuhei, Imai Takahisa, Nishiguchi Maiko, Furuta Mitsuru, Yorifuji Shiro

机构信息

Wakakusa Tatsuma Rehabilitation Hospital, Daito, Japan.

Kansai Rosai Hospital, Amagasaki, Japan.

出版信息

Prog Rehabil Med. 2021 Feb 20;6:20210012. doi: 10.2490/prm.20210012. eCollection 2021.

DOI:10.2490/prm.20210012
PMID:33644483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7897538/
Abstract

OBJECTIVES

Progressive supranuclear palsy (PSP) is an uncommon progressive neurodegenerative disease with no effective cure at present. The initial symptoms resemble those of Parkinson's disease; however, the prevalence of PSP is about one-tenth that of Parkinson's disease. In many cases, dysphagia is severe, and the development of dysphagia is an early predictor of life expectancy. The aim of the current study was to define the effects of Lee Silverman Voice Treatment (LSVT LOUD) on swallowing and voice/speech in seven patients with PSP.

METHODS

: Each patient underwent swallowing and voice/speech evaluations before and after 4 weeks of LSVT. Swallowing motility disorders were defined, temporal measures of swallowing were determined by videofluoroscopic evaluation, and voice measures of maximum phonation and speech intelligibility in reading and monologue were examined.

RESULTS

After LSVT, the median duration of opening of the upper esophageal sphincter (from the beginning of the posterior movement of the bolus to upper esophageal sphincter opening) on videofluoroscopy was significantly shortened from 0.42 to 0.38 s (Wilcoxon signed-rank test P=0.016). The oral transit duration was decreased in five patients, but the decrease was not significant. Voice changes after LSVT included increases in voice intensity and in sustained duration were not significant.

CONCLUSION

In this small study, it was found that LSVT may improve swallowing functions in patients with PSP.

摘要

目的

进行性核上性麻痹(PSP)是一种罕见的进行性神经退行性疾病,目前尚无有效治愈方法。其初始症状与帕金森病相似;然而,PSP的患病率约为帕金森病的十分之一。在许多病例中,吞咽困难严重,吞咽困难的出现是预期寿命的早期预测指标。本研究的目的是确定李·西尔弗曼嗓音治疗(LSVT LOUD)对7例PSP患者吞咽及嗓音/言语的影响。

方法

每位患者在接受LSVT治疗4周前后均接受吞咽及嗓音/言语评估。定义吞咽运动障碍,通过电视荧光透视评估确定吞咽的时间指标,并检查最大发声以及阅读和独白时言语可懂度的嗓音指标。

结果

LSVT治疗后,电视荧光透视显示食管上括约肌开放的中位持续时间(从食团向后移动开始至食管上括约肌开放)从0.42秒显著缩短至0.38秒(Wilcoxon符号秩检验P=0.016)。5例患者的口腔运送时间缩短,但缩短不显著。LSVT治疗后的嗓音变化包括嗓音强度增加,持续时间增加不显著。

结论

在这项小型研究中,发现LSVT可能改善PSP患者的吞咽功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5626/7897538/0294a916d241/prm-6-20210012-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5626/7897538/ed5508d6d698/prm-6-20210012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5626/7897538/071656e1d25d/prm-6-20210012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5626/7897538/0294a916d241/prm-6-20210012-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5626/7897538/ed5508d6d698/prm-6-20210012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5626/7897538/071656e1d25d/prm-6-20210012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5626/7897538/0294a916d241/prm-6-20210012-g003.jpg

相似文献

1
Effects of Lee Silverman Voice Treatment (LSVT LOUD) on Swallowing in Patients with Progressive Supranuclear Palsy: A Pilot Study.李·西尔弗曼嗓音治疗法(LSVT LOUD)对进行性核上性麻痹患者吞咽功能的影响:一项初步研究。
Prog Rehabil Med. 2021 Feb 20;6:20210012. doi: 10.2490/prm.20210012. eCollection 2021.
2
Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.李·西尔曼嗓音治疗(LSVT LOUD®)对帕金森病吞咽和咳嗽的影响:一项初步研究。
J Neurol Sci. 2017 Dec 15;383:180-187. doi: 10.1016/j.jns.2017.11.015. Epub 2017 Nov 15.
3
The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.进行性核上性麻痹的李·西尔弗曼嗓音治疗(LSVT®)言语疗法
Eur J Phys Rehabil Med. 2015 Oct;51(5):569-74. Epub 2015 Jul 3.
4
Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study.李·西尔弗曼嗓音治疗(LSVT)对吞咽及嗓音的影响:一项初步研究。
J Neurol Neurosurg Psychiatry. 2002 Jan;72(1):31-6. doi: 10.1136/jnnp.72.1.31.
5
Swallowing Outcomes Following Voice Therapy in Multiple System Atrophy with Dysphagia: Comparison of Treatment Efficacy with Parkinson's Disease.多系统萎缩伴吞咽困难患者行嗓音治疗后的吞咽结局:与帕金森病的疗效比较。
Dysphagia. 2022 Feb;37(1):198-206. doi: 10.1007/s00455-021-10265-9. Epub 2021 Mar 5.
6
Effects of Intensive Voice Treatment (The Lee Silverman Voice Treatment [LSVT LOUD]) in Subjects With Multiple Sclerosis: A Pilot Study.多发性硬化症患者强化嗓音治疗(李·西尔弗曼嗓音治疗 [LSVT LOUD])的效果:一项初步研究。
J Voice. 2022 Jul;36(4):585.e1-585.e13. doi: 10.1016/j.jvoice.2020.07.025. Epub 2020 Aug 18.
7
Telerehabilitation for Lee Silverman Voice Treatment (Tele-LSVT)-Loud on voice intensity and voice use in daily living in people with multiple sclerosis: A protocol for a feasibility and pilot randomized controlled study.针对多发性硬化症患者的李·西尔弗曼嗓音疗法(远程LSVT)-大声治疗对嗓音强度及日常生活中嗓音使用的影响:一项可行性和试点随机对照研究方案
Digit Health. 2023 Dec 6;9:20552076231218150. doi: 10.1177/20552076231218150. eCollection 2023 Jan-Dec.
8
Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease.李·西尔弗曼嗓音治疗法® LOUD对日语帕金森病患者的疗效
Rehabil Res Pract. 2020 Jan 24;2020:6585264. doi: 10.1155/2020/6585264. eCollection 2020.
9
Case Report: Benefits of LSVT LOUD in a multilingual patient with hypokinetic-hyperkinetic dysarthria and suspected progressive supranuclear palsy.病例报告:大剂量语言发声疗法(LSVT LOUD)对一名患有运动减少-运动增多型构音障碍且疑似进行性核上性麻痹的多语言患者的益处。
Front Rehabil Sci. 2024 Jul 18;5:1421730. doi: 10.3389/fresc.2024.1421730. eCollection 2024.
10
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.李·西尔弗曼语音治疗与英国国民保健制度(NHS)言语和语言治疗对照治疗帕金森病(PD COMM)患者构音障碍的实用性、基于英国、多中心、三臂、平行组、非盲、随机对照试验。
BMJ. 2024 Jul 10;386:e078341. doi: 10.1136/bmj-2023-078341.

引用本文的文献

1
Voice Meets Swallowing: A Scoping Review of Therapeutic Connections.嗓音与吞咽:治疗关联的范围综述
Am J Speech Lang Pathol. 2025 Mar 10;34(2):877-907. doi: 10.1044/2024_AJSLP-24-00194. Epub 2025 Jan 7.
2
Effectiveness of Lee Silverman Voice Treatment (LSVT-LOUD) in Parkinsonian-Type Multiple System Atrophy (MSA-P): A Case Report.李·西尔弗曼嗓音治疗(LSVT-LOUD)对帕金森型多系统萎缩(MSA-P)的疗效:一例报告
Cureus. 2024 Nov 6;16(11):e73106. doi: 10.7759/cureus.73106. eCollection 2024 Nov.
3
Dysphagia Prevalence in Progressive Supranuclear Palsy: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.李·西尔曼嗓音治疗(LSVT LOUD®)对帕金森病吞咽和咳嗽的影响:一项初步研究。
J Neurol Sci. 2017 Dec 15;383:180-187. doi: 10.1016/j.jns.2017.11.015. Epub 2017 Nov 15.
2
Clinical Profile of Dysphagia in Patients with Parkinson's Disease, Progressive Supranuclear Palsy and Multiple System Atrophy.帕金森病、进行性核上性麻痹和多系统萎缩患者吞咽困难的临床特征
J Assoc Physicians India. 2017 Aug;65(8):32-37.
3
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
进行性核上性麻痹吞咽困难的患病率:系统评价和荟萃分析。
Dysphagia. 2024 Dec;39(6):1052-1064. doi: 10.1007/s00455-024-10681-7. Epub 2024 Mar 24.
4
Prevalence of Hoarseness and Its Association with Severity of Dysphagia in Patients with Sarcopenic Dysphagia.肌少性吞咽困难患者声音嘶哑的发生率及其与吞咽困难严重程度的关系。
J Nutr Health Aging. 2022;26(3):266-271. doi: 10.1007/s12603-022-1754-3.
进行性核上性麻痹的临床诊断:运动障碍协会标准。
Mov Disord. 2017 Jun;32(6):853-864. doi: 10.1002/mds.26987. Epub 2017 May 3.
4
Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.进行性核上性麻痹和多系统萎缩生存预测因素的系统评价和荟萃分析。
J Neurol Neurosurg Psychiatry. 2017 May;88(5):402-411. doi: 10.1136/jnnp-2016-314956. Epub 2017 Mar 1.
5
The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.进行性核上性麻痹的李·西尔弗曼嗓音治疗(LSVT®)言语疗法
Eur J Phys Rehabil Med. 2015 Oct;51(5):569-74. Epub 2015 Jul 3.
6
Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.一系列临床诊断的进行性核上性麻痹患者生存的预测因素。
Parkinsonism Relat Disord. 2013 Nov;19(11):980-5. doi: 10.1016/j.parkreldis.2013.06.014. Epub 2013 Aug 19.
7
The integral role of speech production in the science and treatment of Parkinson's disease.言语产生在帕金森病科学与治疗中的整体作用。
Mov Disord. 2012 Jun;27(7):811-3. doi: 10.1002/mds.25046. Epub 2012 Jun 1.
8
Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance-correlation analysis.通过绩效相关分析确定帕金森病语音治疗效果的神经相关性。
Hum Brain Mapp. 2010 Feb;31(2):222-36. doi: 10.1002/hbm.20859.
9
Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease.呼气肌力量训练对帕金森病患者自主咳嗽和吞咽功能的影响。
Chest. 2009 May;135(5):1301-1308. doi: 10.1378/chest.08-1389. Epub 2008 Nov 24.
10
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.进行性核上性麻痹和多系统萎缩的临床结局
Brain. 2008 May;131(Pt 5):1362-72. doi: 10.1093/brain/awn065. Epub 2008 Apr 2.